Injective rises as buyers hold the advantage and upside stays capped

Traders Union
All News
Crypto News
Injective jumps 7.93% to $5.21 today

Highlights

INJ maintains a bullish trend, trading above short-, medium-, and long-term moving averages, confirming sustained upward momentum.
Momentum indicators are predominantly positive, but some short-term oscillators signal caution as overbought conditions appear on lower timeframes.
Price is expected to consolidate between $5.05 and $5.70 this week, with a pullback more likely than a breakout.

Strong trend and buyer control as technicals signal further upside

On the technical front, INJ holds above SMA-20 ($4.62), SMA-50 ($3.81), and SMA-200 ($4.29). The Ichimoku Kijun on the daily chart is at $4.75, serving as immediate support. Intraday, the price is trading near the mid-range between $5.09 and $5.35, after opening with an upward gap. Momentum indicators remain positive: MACD and ADX both confirm trend strength (with ADX at a robust 46.64), while the Awesome Oscillator also supports the uptrend. RSI sits at 67.32, reflecting strong buying control without reaching overbought territory. Stoch RSI (26.14) and CCI (80.53) hint at room for further upside, though some short-term oscillators raise caution with minor divergence and localized overbought readings. BBP underscores heavy buyer dominance.

Consolidation favored as breakout odds remain low in short term

Looking ahead to the coming week, typical volatility places INJ in a likely trading band between $5.05 and $5.70. Analysts note very low probability (less than 20%) for an immediate breakout to the upside, with one key weekly indicator confirming a buy. The base case scenario calls for consolidation or sideways movement between $5.05 and $5.70. A bullish extension would require a firm break and hold above $5.70, while a drop below $5.05 could accelerate a pullback or correction.

Viktoras Karapetjanc, expert at Traders Union, sees Injective maintaining a strong technical posture above key moving averages and support levels. He notes positive momentum indicators and healthy buyer control, while short-term oscillators suggest potential for continued upside. The analyst expects INJ to remain in a consolidation range between $5.05 and $5.70 unless a firm break occurs. Karapetjanc believes sentiment is constructive and trend strength supports holding positions. "Momentum and structure look solid — the path of least resistance remains up as long as $5.05 holds."

Earlier, analysts noted that Injective had maintained a broadly bullish structure amid elevated volatility and emerging downside risks. The current analysis reinforces the prevailing upward momentum while highlighting that a decisive move above $5.70 would be required to confirm any sustained breakout.

Source of Data: INJ Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.